bendroflumethiazide has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies
Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Many patients with COPD use RAS-inhibiting (RASi) treatment." | 1.91 | Renin-angiotensin-system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study. ( Biering-Sørensen, T; Eklöf, J; Hedsund, C; Heerfordt, CK; Hilberg, O; Jensen, JS; Kamstrup, P; Klausen, TW; Kolekar, S; Lund, TK; Pedersen, L; Sivapalan, P; Skaarup, KG; Sørensen, R; Vilstrup, F, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vilstrup, F | 1 |
| Heerfordt, CK | 1 |
| Kamstrup, P | 1 |
| Hedsund, C | 1 |
| Biering-Sørensen, T | 1 |
| Sørensen, R | 1 |
| Kolekar, S | 1 |
| Hilberg, O | 1 |
| Pedersen, L | 1 |
| Lund, TK | 1 |
| Klausen, TW | 1 |
| Skaarup, KG | 1 |
| Eklöf, J | 1 |
| Sivapalan, P | 1 |
| Jensen, JS | 1 |
1 other study available for bendroflumethiazide and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Renin-angiotensin-system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study.
Topics: Angiotensins; Bendroflumethiazide; Enzyme Inhibitors; Humans; Pulmonary Disease, Chronic Obstructive | 2023 |